Oncology Research And Treatment

期刊发文

• Pan-HER tyrosine kinase inhibitor pyrotinib enhances radiosensitivity via ERK1/2 pathway in HER2-positive gastric cancer

  Author: Niu, Qian; Liu, Jiamin; Huang, Tingting; Su, Beibei; Zhang, Yuanyuan; Yuan, Xianglin

  Journal: ONCOLOGY RESEARCH AND TREATMENT. 2023; Vol. 46, Issue 1-2, pp. 11-25. DOI: 10.1159/000528594

• Changes In Tumor Immune Microenvironment After Radiotherapy Resistance In Colorectal Cancer: a Narrative Review

  Author: Wang, Chao; Yuan, Meng; Gao, Yongjian; Hou, Ruizhi; Song, Defeng; Feng, Ye

  Journal: ONCOLOGY RESEARCH AND TREATMENT. 2023; Vol. , Issue , pp. -. DOI: 10.1159/000530161

• Identification and validation of CCNA2 and CCNE2 as potential biomarkers in small cell lung cancer

  Author: Zhang, Xiangxin; Yang, Liu; Huang, Bing; Yin, Jiangwen; Wei, Yutao

  Journal: ONCOLOGY RESEARCH AND TREATMENT. 2023; Vol. , Issue , pp. -. DOI: 10.1159/000530545

• Body Mass Index at Diagnosis as a Prognostic Factor for Early-Stage Invasive Breast Cancer after Surgical Resection.

  Author: Wang X¹, Hui TL¹, Wang MQ¹, Liu H¹, Li RY¹, Song ZC².

  Journal: Oncol Res Treat. 2019;42(4):195-201. doi: 10.1159/000496548. Epub 2019 Mar 8.

• Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer.

  Author: Peng P¹, Chen T², Wang Q³, Zhang Y⁴, Zheng F⁵, Huang S⁶, Tang Y⁷, Yang C⁸, Ding W¹, Ren D⁹, Huang Z¹⁰, Guo Y².

  Journal: Oncol Res Treat. 2019;42(4):165-185. doi: 10.1159/000495473. Epub 2019 Mar 14.

• A Dose-Escalating Pilot Study (NCT03017404) of Pegylated Liposomal Doxorubicin and Cyclophosphamide, Followed by Docetaxel Administration as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer.

  Author: Cheng M¹, Song Z², Qi Y², Wang X², Zhang L², Shi J², Wang M³.

  Journal: Oncol Res Treat. 2019;42(5):269-274. doi: 10.1159/000498993. Epub 2019 Apr 3.

• Epigenetic Function of TET Family, 5-Methylcytosine, and 5-Hydroxymethylcytosine in Hematologic Malignancies.

  Author: Li W^1,2, Xu L³.

  Journal: Oncol Res Treat. 2019 May 3:1-9. doi: 10.1159/000498947. [Epub ahead of print]

• The Value of COX-2, NF-κB, and Blood Routine Indexes in the Prognosis of Malignant Peritoneal Mesothelioma.

  Author: Yin W¹, Zheng G², Su S¹, Liang Y¹.

  Journal: Oncol Res Treat. 2019 May 7:1-8. doi: 10.1159/000499677. [Epub ahead of print]